Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Concerns about omissions in the data presented

被引：0
|
作者：
Kennedy, RD [1 ]
Cuthbert, RG [1 ]
Kettle, PJ [1 ]
Morris, TCM [1 ]
机构：
[1] Queens Univ Belfast, Belfast City Hosp, Belfast, Antrim, North Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 06期
关键词：
D O I：
10.1200/JCO.2001.19.6.1884
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1884 / 1884
页数：1
相关论文
共 50 条
  • [41] Overweight as a poor prognostic factor in non-Hodgkin's lymphoma patients undergoing high-dose chemotherapy and autograft.
    Tarella, C
    Gavarotti, P
    Caracciolo, D
    Argentino, C
    Corradini, P
    Zallio, F
    Novero, D
    Magnani, C
    Pileri, A
    BLOOD, 1998, 92 (10) : 373B - 373B
  • [42] High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Coiffier, B
    Doyen, C
    Morel, P
    Attal, M
    Tilly, H
    Deconinck, E
    Gaulard, P
    Reyes, F
    ANNALS OF ONCOLOGY, 1998, 9 : 5 - 8
  • [43] Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Bastion, Y
    Coiffier, B
    Brice, P
    Bosly, A
    Dupriez, B
    Nouvel, C
    Tilly, H
    Lederlin, P
    Biron, P
    Briere, J
    Gaulard, P
    Reyes, F
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1131 - 1137
  • [44] High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma
    Bierman, PJ
    Vose, JM
    Anderson, JR
    Bishop, MR
    Kessinger, A
    Armitage, JO
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 445 - 450
  • [45] Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients
    Inas A. Asfour
    Sherin El Shazly
    Manal H. Fayek
    Hany M. Hegab
    Soha Raouf
    Mohamed A. R. Moussa
    Biological Trace Element Research, 2006, 110 : 19 - 32
  • [46] Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients
    Asfour, IA
    Shazly, S
    Fayek, MH
    Hegab, HM
    Raouf, S
    Moussa, MAR
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2006, 110 (01) : 19 - 32
  • [47] High-dose therapy and stem cell transplantation (BMT) for relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Shahidi, H
    Gregory, SA
    GuptaBurt, S
    Adler, SS
    Venugopal, P
    Meyer, P
    Korenblit, AD
    Recine, D
    Manson, S
    Kaizer, H
    BLOOD, 1997, 90 (10) : 1023 - 1023
  • [48] Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy
    Janicek, M
    Kaplan, W
    Neuberg, D
    Canellos, GP
    Shulman, LN
    Shipp, MA
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1631 - 1637
  • [49] Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma
    Fagnoni, Philippe
    Milpied, Noel
    Limat, Samuel
    Deconinck, Eric
    Nerich, Virginie
    Foussard, Charles
    Colombat, Philippe
    Harousseau, Jean-Luc
    Woronoff-Lemsi, Marie-Christine
    PHARMACOECONOMICS, 2009, 27 (01) : 55 - 68
  • [50] Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin’s Lymphoma
    Philippe Fagnoni
    Noel Milpied
    Samuel Limat
    Eric Deconinck
    Virginie Nerich
    Charles Foussard
    Philippe Colombat
    Jean-Luc Harousseau
    Marie-Christine Woronoff-Lemsi
    PharmacoEconomics, 2009, 27 : 55 - 68
12345